glp-1 drugs news today Americans are taking weight-loss in record numbers Weight loss drugs and addiction:

Description

Simple enough in theory

The identification of dysregulated incretin secretion and action in both obesity and diabetes led to the revolutionary discovery of incretin-based drugs, such as glucagon-like peptide 1 (GLP-1) receptor agonists (RAs) and dual glucose-dependent insulinotropic peptide (GIP)/GLP-1 RAs [24,25,26,27,28]

GLP-1 +3 Mar 19, 2026 7 min read A shift in what's possible for diabetes and obesity GLP-1 +5 Dec 16, 2025 40 min read Incretins are changing the narrative of chronic kidney disease GLP-1 +3 Dec 11, 2025 10 min read Bariatric surgery in a shot

An increased risk of malformations was observed for liraglutide and semaglutide at doses comparable to those administered in humans

Low-sulfur alternatives When you need to reduce sulfur intake without sacrificing nutrition, these swaps work well: Instead of eggs, try oatmeal or rice-based breakfast options